Patient Search
 |
 |
Neuroblastoma Biology Studies
Multiple Cancer Types
Neuroblastoma (Pediatrics),
Pediatrics
N/A
Benedetti, Daniel
NCT00256763
CCGANBL00B1
Preserving Fertility After Colorectal Cancer: The PREFACE Study
Multiple Cancer Types
Colon,
Rectal
N/A
Holowatyj, Andreana
NCT05239338
VICCGI2186
Novel Gastrointestinal Cancer Markers in Tissue and Biofluids
Gastrointestinal
Gastrointestinal
Gastrointestinal
N/A
Beauchamp, Robert
NCT00899626
VICCGI0283
Prospective, Randomized, Crossover Trial Comparing Recombinant von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women with von Willebrand Disease: The VWD Minimize Study
Multiple Cancer Types
Gynecologic,
Hematologic
III
Wheeler, Allison
NCT02606045
VICCNCBH1961
An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
Multiple Cancer Types
Neuroblastoma (Pediatrics),
Pediatric Solid Tumors
N/A
Kitko, Carrie
NCT01590680
VICCPED1249
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
This study will validate a previously developed pediatric prognostic biomarker algorithm aimed at improving prediction of risk for the later development of chronic graft-versus-host disease (cGvHD) in children and young adults undergoing allogeneic hematopoietic stem cell transplant. By developing an early risk stratification of patients into low-, intermediate-, and high-risk for future cGvHD development (based upon their biomarker profile, before the onset of cGvHD), pre-emptive therapies aimed at preventing the onset of cGvHD can be developed based upon an individual's biological risk profile. This study will also continue research into diagnostic biomarkers of cGvHD, and begin work into biomarker models that predict clinical response to cGvHD therapies.
Not Available
N/A
Kitko, Carrie
NCT04372524
VICCPED2183
A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma or Non-Hodgkin Lymphoma
Multiple Cancer Types
This will be a Phase 1 Open-Label, dose escalation and expansion study of MT-0169 (an Engineered toxin body (ETB) in patients with relapsed or refractory multiple myeloma or non-Hodgkin lymphoma. MT-0169 is an investigational drug that recognizes and binds to the CD38 receptor, which may be found on the surface of multiple myeloma and non-Hodgkin lymphoma cancer cells. It delivers a dose of a modified toxin that kills these cells.
Multiple Myeloma,
Phase I
I
Dholaria, Bhagirathbhai
NCT04017130
VICCHEMP1975
Long Term Follow-up for Early Detection of Lung Cancer in Current or Former Smokers
Lung
Lung
This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.
Lung
N/A
Grogan, Eric
NCT03181256
VICCTHO1730
A Study of miRNA 371 in Patients with Germ Cell Tumors
Urologic
Urologic
This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.
Urologic
N/A
Davis, Nancy
NCT04435756
SWOGUROS1823
Navigation Endoscopy for the Diagnosis of Indeterminate Lung Nodules, VERITAS Study
Lung
Lung
This trial studies how well navigation endoscopy works in diagnosing indeterminate lung nodules. Navigation bronchoscopy is a procedure using technology designed to guide a flexible bronchoscope (a small tube with a camera) through the natural airway route (wind-pipe and bronchi) to access the nodule. Navigation bronchoscopy may be more accurate than the standard computed tomography (CT)-guided biopsy in diagnosing patients with indeterminate lung nodules.
Lung
N/A
Maldonado, Fabien
NCT04250194
VICCTHO19102
